Ozon Pharmaceuticals

Ozon Pharmaceuticals is a Russian manufacturer of pharmaceuticals. The product range is represented in all pharmaceutical niches: traditional low molecular weight pharmaceuticals, production of highly toxic drugs against oncology and complex science-intensive drugs in the field of biotechnology. It produces more than 350 items of finished pharmaceuticals, with an annual output of about 5 billion units.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Ozon Pharmaceuticals balance sheet

Report period2021 2022 2023 2024 Q3 25
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Ozon Pharmaceuticals cash flows

Report period2021 2022 2023 2024 Q3 25 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Ozon Pharmaceuticals multipliers

Report period2021 2022 2023 2024 Q3 25 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Ozon Pharmaceuticals profitability

Report period2021 2022 2023 2024 Q3 25 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Ozon Pharmaceuticals assets
Ozon Pharmaceuticals cash flows
Ozon Pharmaceuticals dividends
2.17%

Ozon Pharmaceuticals dividend policy

The criterion for dividend payment is the Net Debt / EBITDA ratio. The dividend policy envisages the following scenarios: Net Debt / EBITDA > 3x - no dividends are paid; 2x < Net Debt / EBITDA ≤ 3x - at least 15% of Net Profit; 1x < Net Debt / EBITDA ≤ 2x - at least 25% of Net Profit; 0x < Net Profit / EBITDA ≤ 1x - at least 35% of Net Profit, but not more than 100% of free cash flow; Net Profit / EBITDA = 0x - at least 50% of Net Profit, but not more than 100% of free cash flow.
Ozon Pharmaceuticals operating results
by quarter
Number of periods: 2
Report periodQ324Q325
Average cost of packaging, rubles
Number of SKU, pieces
Packaging, Millions of pieces
Share of international nonproprietary names, percent
The share of prescription drugs in turnover, percent
The share of retail sales in turnover, percent
The share of vital and essential medicines, percent

Ozon Pharmaceuticals shares

TickerNameTypeNominal valueISINPrice
OZPH:RMOzon PharmaceuticalsCommon shareRUB 0.02RU000A109B25RUB 52.58

Ozon Pharmaceuticals bonds

NameIssue sizePriceYield
Ozon 001P-01 (RUB)1,000,000 pcs.99.87%10.13%
Ozon 001P-02 (RUB)700,000 pcs.99.35%11.33%

Ozon Pharmaceuticals expected events

DateTypeNoteSource
16.04.2026 10:00
Other Issuer Events
Investor's DayPictogram of ozonpharm.ru  ozonpharm.ru
24.04.2026 10:00
Financial results
Reporting for 2025 under IFRS (presumably)Pictogram of e-disclosure.ru  e-disclosure.ru
27.08.2026 10:00
Financial results
Financial statements for 6 months of 20264 in accordance with IFRS (presumably)Pictogram of e-disclosure.ru  e-disclosure.ru
Share capital structure of Ozon Pharmaceuticals
Ozon Pharmaceuticals news
16.01.2026
Ozon Pharmaceuticals Group presents a new packaging No. 20 of the popular drug Immunotresan. Since entering the market in September 2025, more than 300,000 packages of the drug have been sold in packaging No. 10. It combines immunomodulatory and adaptogenic properties, which makes Immunotresan especially relevant during the cold season and the period of incr...
Source: ozonpharm.ru pictogram ozonpharm.ru
Pictogram next
25.12.2025
Shareholders of Ozon Pharmaceuticals approved dividends for 9 months 2025 in the amount of ₽0.27 per ordinary share. The last day of purchase of securities to receive dividends is January 9, 2026. Dividend yield may amount to 0.53%.
Source: e-disclosure.ru pictogram e-disclosure.ru
Pictogram next
25.11.2025
Board of Directors of Ozon Pharmaceuticals recommended that dividends be paid for 9 months 2025 in the amount of ₽0.27 per ordinary share. The last day of the purchase of securities to receive dividends is January 9, 2026. Dividend yield may amount to 0.53%.
Source: e-disclosure.ru pictogram e-disclosure.ru
Pictogram next
25.11.2025
Sales of Ozon Pharmaceuticals for 9 months of 2025 amounted to 241.5 million packages of medicines, an increase of 8% compared to the previous year. In the public procurement segment, sales increased by 19% to 76.7 million packages. Retail sales increased by 4% to 164.8 million packages.
Source: ozonpharm.ru pictogram ozonpharm.ru
Pictogram next
All Ozon Pharmaceuticals news
General information
Company nameOzon Pharmaceuticals
Tags#pharmacy, #biotechnology, #ipo2024
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business addressRF, Samarskaya oblast, g. Zhigulevsk, ul. Gidrostroiteley, d. 6
Mailing address445351, Samarskaya oblast, g. Zhigulevsk, ul. Gidrostroiteley, d. 6
Websiteozonpharm.ru
Information disclosuree-disclosure.ru